141 related articles for article (PubMed ID: 8750925)
1. Cytochromes of the P450 2C subfamily are the major enzymes involved in the O-demethylation of verapamil in humans.
Busse D; Cosme J; Beaune P; Kroemer HK; Eichelbaum M
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 353(1):116-21. PubMed ID: 8750925
[TBL] [Abstract][Full Text] [Related]
2. Identification of P450 enzymes involved in metabolism of verapamil in humans.
Kroemer HK; Gautier JC; Beaune P; Henderson C; Wolf CR; Eichelbaum M
Naunyn Schmiedebergs Arch Pharmacol; 1993 Sep; 348(3):332-7. PubMed ID: 8232610
[TBL] [Abstract][Full Text] [Related]
3. Regiochemistry and substrate stereoselectivity of O-demethylation of verapamil in the presence of the microsomal fraction from rat and human liver.
Nelson WL; Olsen LD; Beitner DB; Pallow RJ
Drug Metab Dispos; 1988; 16(2):184-8. PubMed ID: 2898330
[TBL] [Abstract][Full Text] [Related]
4. CYP2C subfamily, primarily CYP2C9, catalyses the enantioselective demethylation of the endocrine disruptor pesticide methoxychlor in human liver microsomes: use of inhibitory monoclonal antibodies in P450 identification.
Hu Y; Krausz K; Gelboin HV; Kupfer D
Xenobiotica; 2004 Feb; 34(2):117-32. PubMed ID: 14985143
[TBL] [Abstract][Full Text] [Related]
5. Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites.
Sutton D; Butler AM; Nadin L; Murray M
J Pharmacol Exp Ther; 1997 Jul; 282(1):294-300. PubMed ID: 9223567
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 2C9 catalyzes indomethacin O-demethylation in human liver microsomes.
Nakajima M; Inoue T; Shimada N; Tokudome S; Yamamoto T; Kuroiwa Y
Drug Metab Dispos; 1998 Mar; 26(3):261-6. PubMed ID: 9492390
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites.
Botsch S; Gautier JC; Beaune P; Eichelbaum M; Kroemer HK
Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765
[TBL] [Abstract][Full Text] [Related]
8. Cytochromes P450, 1A2, and 2C9 are responsible for the human hepatic O-demethylation of R- and S-naproxen.
Miners JO; Coulter S; Tukey RH; Veronese ME; Birkett DJ
Biochem Pharmacol; 1996 Apr; 51(8):1003-8. PubMed ID: 8866821
[TBL] [Abstract][Full Text] [Related]
9. Contribution of human cytochrome p-450 isoforms to the metabolism of the simplest phenothiazine neuroleptic promazine.
Wójcikowski J; Pichard-Garcia L; Maurel P; Daniel WA
Br J Pharmacol; 2003 Apr; 138(8):1465-74. PubMed ID: 12721102
[TBL] [Abstract][Full Text] [Related]
10. Differential enantioselectivity and product-dependent activation and inhibition in metabolism of verapamil by human CYP3As.
Shen L; Fitzloff JF; Cook CS
Drug Metab Dispos; 2004 Feb; 32(2):186-96. PubMed ID: 14744940
[TBL] [Abstract][Full Text] [Related]
11. [O-methyl 14C]naproxen O-demethylase activity in human liver microsomes: evidence for the involvement of cytochrome P4501A2 and P4502C9/10.
Rodrigues AD; Kukulka MJ; Roberts EM; Ouellet D; Rodgers TR
Drug Metab Dispos; 1996 Jan; 24(1):126-36. PubMed ID: 8825200
[TBL] [Abstract][Full Text] [Related]
12. Involvement of multiple cytochrome P450 isoforms in naproxen O-demethylation.
Tracy TS; Marra C; Wrighton SA; Gonzalez FJ; Korzekwa KR
Eur J Clin Pharmacol; 1997; 52(4):293-8. PubMed ID: 9248768
[TBL] [Abstract][Full Text] [Related]
13. Human cytochrome P450-catalyzed conversion of the proestrogenic pesticide methoxychlor into an estrogen. Role of CYP2C19 and CYP1A2 in O-demethylation.
Stresser DM; Kupfer D
Drug Metab Dispos; 1998 Sep; 26(9):868-74. PubMed ID: 9733665
[TBL] [Abstract][Full Text] [Related]
14. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
[TBL] [Abstract][Full Text] [Related]
15. Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily.
Gorski JC; Jones DR; Wrighton SA; Hall SD
Biochem Pharmacol; 1994 Jul; 48(1):173-82. PubMed ID: 8043020
[TBL] [Abstract][Full Text] [Related]
16. Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4.
Foster DJ; Somogyi AA; Bochner F
Br J Clin Pharmacol; 1999 Apr; 47(4):403-12. PubMed ID: 10233205
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of sulfaphenazole derivatives and their use as inhibitors and tools for comparing the active sites of human liver cytochromes P450 of the 2C subfamily.
Ha-Duong NT; Dijols S; Marques-Soares C; Minoletti C; Dansette PM; Mansuy D
J Med Chem; 2001 Oct; 44(22):3622-31. PubMed ID: 11606127
[TBL] [Abstract][Full Text] [Related]
18. Rapid and highly sensitive method for the determination of verapamil, [2H7]verapamil and metabolites in biological fluids by liquid chromatography-mass spectrometry.
von Richter O; Eichelbaum M; Schönberger F; Hofmann U
J Chromatogr B Biomed Sci Appl; 2000 Jan; 738(1):137-47. PubMed ID: 10778935
[TBL] [Abstract][Full Text] [Related]
19. In vitro sulfoxidation of thioether compounds by human cytochrome P450 and flavin-containing monooxygenase isoforms with particular reference to the CYP2C subfamily.
Usmani KA; Karoly ED; Hodgson E; Rose RL
Drug Metab Dispos; 2004 Mar; 32(3):333-9. PubMed ID: 14977868
[TBL] [Abstract][Full Text] [Related]
20. (R)-, (S)-, and racemic fluoxetine N-demethylation by human cytochrome P450 enzymes.
Margolis JM; O'Donnell JP; Mankowski DC; Ekins S; Obach RS
Drug Metab Dispos; 2000 Oct; 28(10):1187-91. PubMed ID: 10997938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]